As artificial intelligence (AI) and brain technologies develop at a breathtaking speed, scientists are warning that one of the oldest and most important questions in science remains unanswered: what is consciousness?
Is an education that responds to children’s ongoing brain development, supporting social and emotional development, the key to addressing the youth mental health crisis?
Dr. Gerardo Fernandez, CSO ViewMind Inc, investigates how early is too early for the detection of Alzheimer’s disease and how soon in the disease’s trajectory detection can make a meaningful difference in a patient’s prognosis.
A survey looking at ayahuasca dangers finds 70% experience physical and 55% mental health adverse effects – but only 2.3% of physical adverse events require medical attention.
Sean Lawler, Associate Professor at Brown University pursues an understanding of cancer through the lens of the molecular and cellular ecosystem and natural selection.
COVID-19 activates the same inflammatory response in the brain as Parkinson’s disease – increasing the risk of future potential neurodegenerative conditions.
Sabine Hölter, Coordinator of the European Brain Research Area cluster PREMOS, calls attention to the translational value of animal models in brain research.
Including cranberries in your diet has a whole host of benefits - it can improve memory and brain function, lower ‘bad’ cholesterol and prevent dementia.
More than half of neurointerventionalists, neurosurgeons, neurologists and radiologists are currently experiencing burnout as a result of provider shortages, covering multiple hospitals simultaneously, and increasing demand for emergency stroke care, and this is only expected to get worse.
To improve understanding of the impact and epidemiology of Alzheimer’s disease, Project Alzheimer’s Value Europe (PAVE) demonstrates the prevalence of Alzheimer’s across the stages of the disease, including prodromal and preclinical – which aren’t recognised by previous studies.
